Exploring the next growth areas and strengthening the technology base
First written in FY2016-Q2. 24 of 41 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-10-09.
Osaka Organic Chemical Industry moved to the "Worse" side of this theme in 2023, 3 years after the typical company in this theme (2020).
15 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「As a result, revenue was ¥3,668 million, up 20.0% year on year, and segment profit was ¥990 million, up 60.4%.」
Revenue in the Functional Chemicals business increased 20.0% year on year, while segment profit increased 60.4%. Sales of cosmetic ingredients and high-purity specialty solvents were strong, and sales of functional materials also increased substantially. - FY2025-H1AdvancedAnnual report
「In the Functional Chemicals business, sales remained flat in both the Cosmetic Ingredients Group and the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents remained strong. As a result, revenue was ¥3,058 million, up 13.8% year on year, and segment profit was ¥617 million, up 73.3%.」
While sales of cosmetic ingredients and functional materials were flat, the subsidiary's high-purity specialty solvents performed strongly, resulting in a 13.8% increase in revenue and a 73.3% increase in segment profit in the Functional Chemicals business. - FY2024-Q2WorsenedAnnual report
「Overseas sales of cosmetic ingredients remained steady, but sales of contract-manufactured products remained weak and sales of high-purity specialty solvents declined. As a result, revenue was ¥2,686 million, down 13.8% year on year, and segment profit was ¥356 million, down 36.7%.」
Steady overseas sales of cosmetic ingredients were offset by weak sales of contract-manufactured products and lower sales of high-purity specialty solvents, resulting in a 13.8% decline in revenue and a 36.7% decline in segment profit. - FY2024-Q1WorsenedAnnual report
「In the Functional Chemicals business, overseas sales remained steady in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained weak in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents declined. As a result, revenue was ¥1,264 million, down 16.5% year on year, and segment profit was ¥132 million, down 56.1%.」
Steady overseas sales of cosmetic ingredients were offset by weak sales of contract-manufactured products and lower sales of high-purity specialty solvents, resulting in lower revenue for the Functional Chemicals business and a 56.1% decline in segment profit. - FY2023WorsenedAnnual report
「As a result, revenue was ¥5,828 million, down 2.5% year on year, and segment profit was ¥973 million, down 25.1%.」
In the Functional Chemicals business, steady overseas sales of cosmetic ingredients and high-purity specialty solvents were offset by weak sales of contract-manufactured products, resulting in a 2.5% decline in revenue and a 25.1% decline in segment profit. - FY2023-Q3WorsenedAnnual report
「In the Functional Chemicals business, overseas sales remained steady in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained weak in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents remained steady. As a result, revenue was ¥4,479 million, up 0.1% year on year, and segment profit was ¥777 million, down 24.1%.」
Overseas sales of cosmetic ingredients and high-purity specialty solvents remained steady, but weak sales of contract-manufactured products resulted in nearly flat revenue and a 24.1% decline in segment profit. - FY2023-Q2WorsenedAnnual report
「In the Functional Chemicals business, overseas sales remained strong in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained weak in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents also remained strong. As a result, revenue was ¥3,115 million, up 5.6% year on year, and segment profit was ¥563 million, down 18.6%.」
Sales of cosmetic ingredients and high-purity specialty solvents were strong, but weak sales of contract-manufactured products resulted in a 5.6% increase in revenue and an 18.6% decline in segment profit. - FY2023-Q1WorsenedAnnual report
「In the Functional Chemicals business, overseas sales remained strong in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained weak in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents remained steady. As a result, revenue was ¥1,514 million, up 7.0% year on year, and segment profit was ¥301 million, down 7.1%.」
Overseas sales of cosmetic ingredients and high-purity specialty solvents remained steady, but weak sales of contract-manufactured products resulted in a 7.0% increase in revenue and a 7.1% decline in segment profit. - FY2022WorsenedAnnual report
「In the Functional Chemicals business, overseas sales remained strong in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained weak in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents remained strong. As a result, revenue was ¥5,976 million, with no year-on-year comparison available, and segment profit was ¥1,299 million, down 12.8% year on year.」
Overseas sales of cosmetic ingredients and high-purity specialty solvents were strong, but weak sales of contract-manufactured products resulted in segment profit of ¥1,299 million, down 12.8% year on year, in the Functional Chemicals business. - FY2022-Q3WorsenedAnnual report
「In the Cosmetic Ingredients Group, overseas sales of acrylic resins for hair-care products acquired from Mitsubishi Chemical Corporation last year remained strong. Sales of contract-manufactured products in the Functional Materials Group were flat. The subsidiary's sales of high-purity specialty solvents remained strong. As a result, revenue was ¥4,476 million, with no year-on-year comparison available, and segment profit was ¥1,023 million, down 5.0% year on year.」
Overseas sales of acrylic resins for hair-care products and sales of high-purity specialty solvents were strong, but sales of contract-manufactured products were flat, resulting in a 5.0% year-on-year decline in segment profit in the Functional Chemicals business. - FY2022-Q2AdvancedAnnual report
「In the Functional Chemicals business, overseas sales of acrylic resins for hair-care products acquired from Mitsubishi Chemical Corporation last year remained strong in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained steady in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents also remained strong. As a result, revenue was ¥2,950 million, with no year-on-year comparison available, and segment profit was ¥691 million, up 1.9% year on year.」
Overseas sales of acrylic resins for hair-care products and sales of contract-manufactured products and high-purity specialty solvents remained steady or strong, and segment profit was ¥691 million, up 1.9% year on year. - FY2022-Q1AdvancedAnnual report
「In the Functional Chemicals business, overseas sales of acrylic resins for hair-care products acquired from Mitsubishi Chemical Corporation last year remained strong in the Cosmetic Ingredients Group. Sales of contract-manufactured products remained steady in the Functional Materials Group. The subsidiary's sales of high-purity specialty solvents also remained strong. As a result, revenue was ¥1,415 million, with no year-on-year comparison available, and segment profit was ¥324 million, up 1.0% year on year.」
Overseas sales of acrylic resins for hair-care products and sales of contract-manufactured products and high-purity specialty solvents remained strong, and segment profit was ¥324 million, up 1.0% year on year. - FY2021AdvancedAnnual report
「In the Functional Chemicals business, the Cosmetic Ingredients Group reported higher revenue as demand, which had declined due to the spread of COVID-19, began a gradual recovery, and following the business transfer from Mitsubishi Chemical Corporation of the manufacturing and sales operations for acrylic resins used in hair-care products, effective 1 February 2021. The Functional Materials Group also reported higher revenue as sales of contract-manufactured products remained steady. Segment profit increased substantially, mainly due to the higher proportion of high-margin products. As a result, revenue was ¥8,462 million, up 35.0% year on year, and segment profit was ¥1,490 million, up 44.9%.」
Driven by the recovery in demand for cosmetic ingredients, the business acquisition, sales of contract-manufactured products and a higher proportion of high-margin products, revenue in the Functional Chemicals business increased 35.0% and segment profit increased 44.9%. - FY2021-Q3AdvancedAnnual report
「In the Functional Chemicals business, the Cosmetic Ingredients Group reported higher revenue as demand, which had declined due to the spread of COVID-19, began a gradual recovery, and following the business transfer from Mitsubishi Chemical Corporation of the manufacturing and sales operations for acrylic resins used in hair-care products, effective 1 February 2021. The Functional Materials Group also reported higher revenue as sales of contract-manufactured products remained steady. Segment profit increased substantially, mainly due to the higher proportion of high-margin products. As a result, revenue was ¥6,088 million, up 30.6% year on year, and segment profit was ¥1,077 million, up 40.8%.」
Driven by the recovery in demand for cosmetic ingredients, the acquisition of the acrylic resin business for hair-care products, sales of contract-manufactured products and a higher proportion of high-margin products, the Functional Chemicals segment posted a 30.6% increase in revenue and a 40.8% increase in segment profit. - FY2021-Q2AdvancedAnnual report
「In the Functional Chemicals business, the Cosmetic Ingredients Group reported higher revenue as demand, which had declined due to the spread of COVID-19, began a gradual recovery, and following the business transfer from Mitsubishi Chemical Corporation of the manufacturing and sales operations for acrylic resins used in hair-care products, effective 1 February 2021. The Functional Materials Group also reported higher revenue as sales of contract-manufactured products remained steady. Segment profit increased substantially, mainly due to the higher proportion of high-margin products. As a result, revenue was ¥3,727 million, up 19.3% year on year, and segment profit was ¥678 million, up 30.8%.」
Driven by the recovery in demand for cosmetic ingredients, the acquisition of the acrylic resin business for hair-care products, sales of contract-manufactured products and a higher proportion of high-margin products, revenue increased 19.3% and segment profit increased 30.8%. - FY2021-Q1AdvancedAnnual report
「In the Functional Chemicals business, demand that had stagnated due to the spread of COVID-19 was on a gradual recovery trend in the Cosmetic Ingredients Group, and sales increased. Sales of contract-manufactured products remained firm in the Functional Materials Group and increased. Segment profit also increased significantly due to a higher proportion of high-margin products and other factors. As a result, sales were ¥1,689 million, up 13.6% from the same quarter of the previous year, and segment profit was ¥321 million, up 35.8%.」
Driven by the recovery in demand for cosmetic ingredients, steady sales of contract-manufactured products and a higher proportion of high-margin products, the Functional Chemicals segment posted a 13.6% increase in revenue and a 35.8% increase in segment profit. - FY2020AdvancedAnnual report
「In the Functional Chemicals business, sales of cosmetics in the Cosmetic Ingredients Group remained sluggish and declined due to increased working from home and fewer opportunities to go out. Sales in the Functional Materials Group declined due to lower sales of contract-manufactured products. However, segment profit increased due to a higher proportion of high-margin products. As a result, sales were ¥6,268 million, down 1.1% year on year, and segment profit was ¥1,020 million, up 29.7%.」
Functional Chemicals sales declined, while segment profit increased 29.7% due to a higher proportion of high-margin products, confirming improved profitability on a full-year basis. - FY2020-Q3AdvancedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group were flat. Sales in the Functional Materials Group remained sluggish and declined. However, segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥4,661 million, down 0.5% from the same quarter of the previous year, and segment profit was ¥764 million, up 35.4%.」
Functional Chemicals sales declined slightly, while segment profit increased 35.4% due to a higher proportion of high-margin products. - FY2020-Q2AdvancedAnnual report
「In the Functional Chemicals business, the Company promoted the development of functional polymers and worked to expand sales of cosmetic ingredients and high-purity specialty solvents. Sales in the Cosmetic Ingredients Group remained firm and increased. Sales in the Functional Materials Group were sluggish and declined. However, segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥3,124 million, down 0.5% from the same quarter of the previous year, and segment profit was ¥516 million, up 44.4%.」
The Company advanced the development of functional polymers and expanded sales of cosmetic ingredients and high-purity specialty solvents. Although Functional Chemicals sales declined, segment profit increased 44.4% due to a higher proportion of high-margin products. - FY2020-Q1AdvancedAnnual report
「In the Functional Chemicals business, the Company promoted the development of functional polymers and worked to expand sales of cosmetic ingredients and high-purity specialty solvents. Sales in the Cosmetic Ingredients Group remained firm and increased. Sales in the Functional Materials Group also remained firm and increased. Segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥1,487 million, up 1.5% from the same quarter of the previous year, and segment profit was ¥238 million, up 71.8%.」
The Company advanced the development of functional polymers and expanded sales of cosmetic ingredients and high-purity specialty solvents, resulting in a 1.5% increase in Functional Chemicals sales and a 71.8% increase in segment profit. - FY2019WorsenedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group remained sluggish and declined. Sales in the Functional Materials Group also declined. Segment profit declined due to a lower proportion of high-margin products. As a result, sales were ¥6,340 million, down 6.8% year on year, and segment profit was ¥787 million, down 5.3%.」
In the Functional Chemicals business, sales declined 6.8% and segment profit declined 5.3% due to lower sales of cosmetic ingredients and functional materials and a lower proportion of high-margin products. - FY2019-Q3WorsenedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group remained sluggish and declined. Sales in the Functional Materials Group also declined. Segment profit declined due to a lower proportion of high-margin products. As a result, sales were ¥4,686 million, down 7.4% from the same quarter of the previous year, and segment profit was ¥564 million, down 16.9%.」
Functional Chemicals sales declined 7.4%, while segment profit also declined 16.9% due to a lower proportion of high-margin products. - FY2019-Q2WorsenedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group remained sluggish and declined. Sales in the Functional Materials Group also declined. Segment profit declined significantly due to a lower proportion of high-margin products. As a result, sales were ¥3,140 million, down 6.9% from the same quarter of the previous year, and segment profit was ¥357 million, down 19.9%.」
The Company advanced its policy of developing functional polymers and expanding sales of cosmetic ingredients and specialty solvents, but sales declined 6.9% and segment profit declined 19.9% due to a lower proportion of high-margin products. - FY2019-Q1WorsenedAnnual report
「In the Functional Chemicals business, the Company promoted the development of functional polymers and worked to expand sales of cosmetic ingredients and specialty solvents. Sales in the Functional Materials Group were flat. Segment profit declined significantly due to a lower proportion of high-margin products. As a result, sales were ¥1,464 million, down 7.4% from the same quarter of the previous year, and segment profit was ¥138 million, down 35.4%.」
The Company advanced the development of functional polymers and expanded sales of cosmetic ingredients and specialty solvents, but sales declined 7.4% and segment profit declined 35.4% due to a lower proportion of high-margin products. - FY2018AdvancedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group were flat. Sales in the Functional Materials Group remained strong and increased. Segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥7,021 million, up 11.2% year on year, and segment profit was ¥830 million, up 29.1%.」
In the Functional Chemicals business, increased sales in the Functional Materials Group and a higher proportion of high-margin products resulted in an 11.2% increase in full-year sales and a 29.1% increase in segment profit. - FY2018-Q3AdvancedAnnual report
「In addition, in the Functional Chemicals business, the Company worked to develop new fields and strengthen overseas sales, while improving profitability through rationalization and expanded sales of existing products. Sales in the Cosmetic Ingredients Group remained strong and increased. Sales in the Functional Materials Group also remained strong and increased. Segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥5,228 million, up 12.9% from the same quarter of the previous year, and segment profit was ¥679 million, up 32.8%.」
In the Functional Chemicals business, higher sales of cosmetic ingredients and functional materials and a higher proportion of high-margin products resulted in a 12.9% increase in sales and a 32.8% increase in segment profit. - FY2018-Q2AdvancedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group remained strong and increased. Sales in the Functional Materials Group also remained strong and increased. Segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥3,476 million, up 13.9% from the same quarter of the previous year, and segment profit was ¥446 million, up 33.9%.」
Higher sales of cosmetic ingredients and functional materials, together with a higher proportion of high-margin products, resulted in a 13.9% increase in sales and a 33.9% increase in segment profit. - FY2018-Q1AdvancedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group remained strong and increased. Sales in the Functional Materials Group also remained strong and increased. Segment profit increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥1,627 million, up 15.9% from the same quarter of the previous year, and segment profit was ¥214 million, up 58.4%.」
Higher sales of cosmetic ingredients and functional materials, together with a higher proportion of high-margin products, resulted in a 15.9% increase in sales and a 58.4% increase in segment profit. - FY2017AdvancedAnnual report
「In the Functional Chemicals business, sales in the Cosmetic Ingredients Group were flat. Sales in the Functional Materials Group remained strong and increased. Segment profit also increased significantly due to a higher proportion of high-margin products. As a result, sales were ¥6,316 million, up 12.0% year on year, and segment profit was ¥643 million, up 28.2%.」
In the Functional Chemicals business, increased sales in the Functional Materials Group and a higher proportion of high-margin products were reported, resulting in a 12.0% increase in full-year sales and a 28.2% increase in segment profit. - FY2017-Q3AdvancedAnnual report
「In addition, in the Functional Chemicals business, the Company worked to develop new fields and strengthen overseas sales, while improving profitability through rationalization and expanded sales of existing products. Sales in the Functional Materials Group remained strong and increased. Segment profit also increased significantly due to a higher proportion of high-margin products.」
The Company continued to develop new fields, expand overseas sales, and rationalize and expand sales of existing products in the Functional Chemicals business. For the cumulative third quarter period, the Company reported increased sales in the Functional Materials Group and a higher proportion of high-margin products. - FY2017-Q2RestatedAnnual report
「In addition, in the Functional Chemicals business, the Company worked to develop new fields and strengthen overseas sales, while improving profitability through rationalization and expanded sales of existing products.」
The Company continues to develop new fields, expand overseas sales, and improve profitability through the rationalization and expanded sales of existing products in the Functional Chemicals business. - FY2017-Q1RestatedAnnual report
「In the Functional Chemicals business, the Company worked to develop new fields and strengthen overseas sales, while improving profitability through rationalization and expanded sales of existing products.」
The Company continues to develop new fields, expand overseas sales, and improve profitability through the rationalization and expanded sales of existing products in the Functional Chemicals business. - FY2016RestatedAnnual report
「The Company will continue to actively promote joint research with public research institutions and develop distinctive functional materials.」
The Company continues to pursue the development of growth areas and functional materials based on functional polymerization, precision organic synthesis and purification technologies. - FY2016-Q3RestatedAnnual report
「The Company will further expand its technology base in functional polymerization, precision organic synthesis and purification technologies, while pursuing the development of the next generation of growth areas.」
The Company continues to indicate its policy of expanding the technology base in the Functional Chemicals business and developing the next generation of growth areas. - FY2016-Q2First statedAnnual report
「The Company will further expand its technology base in functional polymerization, precision organic synthesis and purification technologies, while pursuing the development of the next generation of growth areas.」
The Company intends to expand functional polymerization, precision organic synthesis and purification technologies and develop the next generation of growth areas in the Functional Chemicals business.